- Home
- IMTE vs POAI Comparison
IMTE vs POAI Comparison
Compare IMTE & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTE
- POAI
- Stock Information
- Founded
- IMTE 2008
- POAI 2002
- Country
- IMTE Malaysia
- POAI United States
- Employees
- IMTE N/A
- POAI N/A
- Industry
- IMTE Consumer Electronics/Appliances
- POAI Industrial Specialties
- Sector
- IMTE Consumer Staples
- POAI Health Care
- Exchange
- IMTE Nasdaq
- POAI Nasdaq
- Market Cap
- IMTE 4.5M
- POAI 4.9M
- IPO Year
- IMTE N/A
- POAI N/A
- Fundamental
- Price
- IMTE $1.21
- POAI $0.69
- Analyst Decision
- IMTE
- POAI Hold
- Analyst Count
- IMTE 0
- POAI 1
- Target Price
- IMTE N/A
- POAI N/A
- AVG Volume (30 Days)
- IMTE 93.5K
- POAI 119.5K
- Earning Date
- IMTE 12-27-2024
- POAI 11-12-2024
- Dividend Yield
- IMTE N/A
- POAI N/A
- EPS Growth
- IMTE N/A
- POAI N/A
- EPS
- IMTE N/A
- POAI N/A
- Revenue
- IMTE $383,813.00
- POAI $1,484,223.00
- Revenue This Year
- IMTE N/A
- POAI N/A
- Revenue Next Year
- IMTE N/A
- POAI $502.91
- P/E Ratio
- IMTE N/A
- POAI N/A
- Revenue Growth
- IMTE 4.75
- POAI N/A
- 52 Week Low
- IMTE $1.06
- POAI $0.55
- 52 Week High
- IMTE $3.84
- POAI $3.76
- Technical
- Relative Strength Index (RSI)
- IMTE 41.65
- POAI 44.88
- Support Level
- IMTE $1.15
- POAI $0.70
- Resistance Level
- IMTE $1.28
- POAI $0.89
- Average True Range (ATR)
- IMTE 0.25
- POAI 0.11
- MACD
- IMTE -0.05
- POAI 0.00
- Stochastic Oscillator
- IMTE 4.42
- POAI 14.64
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.